​

Alaunos Therapeutics (TCRT) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Alaunos Therapeutics Revenue Highlights

Latest Revenue (Y)

$5.00K

Latest Revenue (Q)

$4.00K

Alaunos Therapeutics Revenue by Period

Alaunos Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$5.00K-99.83%
2022-12-31$2.92M634.17%
2021-12-31$398.00K100.00%
2020-12-31-100.00%
2019-12-31--100.00%
2018-12-31$146.00K-97.71%
2017-12-31$6.39M-6.88%
2016-12-31$6.86M58.38%
2015-12-31$4.33M215.51%
2014-12-31$1.37M71.63%
2013-12-31$800.00K-
2012-12-31$800.00K19.94%
2011-12-31$667.00K100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-12-31-100.00%
2007-12-31-100.00%
2006-12-31-100.00%
2005-12-31-100.00%
2004-12-31-100.00%
2003-12-31--100.00%
2002-12-31$2.57K48.90%
2001-12-31$1.73K-

Alaunos Therapeutics generated $5.00K in revenue during NA 2023, up -99.83% compared to the previous quarter, and up 3.42% compared to the same period a year ago.

Alaunos Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30$4.00K300.00%
2024-03-31$1.00K-
2023-12-31$1.00K100.00%
2023-09-30--100.00%
2023-06-30$4.00K100.00%
2023-03-31--100.00%
2022-12-31$11.00K-99.62%
2022-09-30$2.91M100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31--100.00%
2021-09-30$398.00K100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30--100.00%
2018-03-31$146.00K-90.86%
2017-12-31$1.60M-0.06%
2017-09-30$1.60M0.06%
2017-06-30$1.60M-
2017-03-31$1.60M-
2016-12-31$1.60M-0.06%
2016-09-30$1.60M-5.83%
2016-06-30$1.70M-13.81%
2016-03-31$1.97M2.61%
2015-12-31$1.92M2.68%
2015-09-30$1.87M587.13%
2015-06-30$272.00K-
2015-03-31$272.00K-20.00%
2014-12-31$340.00K-46.29%
2014-09-30$633.00K216.50%
2014-06-30$200.00K-
2014-03-31$200.00K-
2013-12-31$200.00K-
2013-09-30$200.00K-
2013-06-30$200.00K-
2013-03-31$200.00K-
2012-12-31$200.00K-
2012-09-30$200.00K-
2012-06-30$200.00K-
2012-03-31$200.00K-
2011-12-31$200.00K-
2011-09-30$200.00K-
2011-06-30$200.00K198.51%
2011-03-31$67.00K100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31-100.00%
2008-12-31-100.00%
2008-09-30-100.00%
2008-06-30-100.00%
2008-03-31-100.00%
2007-12-31--

Alaunos Therapeutics generated $4.00K in revenue during Q2 2024, up 300.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Alaunos Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
RIGLRigel Pharmaceuticals$116.88M$55.31M
ADAPAdaptimmune Therapeutics$60.28M$128.23M
MRSNMersana Therapeutics$36.85M$12.60M
FENCFennec Pharmaceuticals$21.64M$6.97M
STOKStoke Therapeutics$8.78M$4.89M
CUECue Biopharma$5.49M$3.34M
VRCAVerrica Pharmaceuticals$5.12M$-1.86M
CKPTCheckpoint Therapeutics$103.00K-
TCRTAlaunos Therapeutics$5.00K$4.00K
BDTXBlack Diamond Therapeutics--
INKTMiNK Therapeutics--
ACHLAchilles Therapeutics--
LRMRLarimar Therapeutics--

TCRT Revenue FAQ

What is Alaunos Therapeutics’s yearly revenue?

Alaunos Therapeutics's yearly revenue for 2023 was $5K, representing a decrease of -99.83% compared to 2022. The company's yearly revenue for 2022 was $2.92M, representing an increase of 634.17% compared to 2021. TCRT's yearly revenue for 2021 was $398K, representing an increase of 100.00% compared to 2020.

What is Alaunos Therapeutics’s quarterly revenue?

Alaunos Therapeutics's quarterly revenue for Q2 2024 was $4K, a 300.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1K, a 0% increase from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). TCRT's quarterly revenue for Q4 2023 was $1K, a 100.00% increase from the previous quarter (Q3 2023), and a -90.91% decrease year-over-year (Q4 2022).

What is Alaunos Therapeutics’s revenue growth rate?

Alaunos Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -98.74%, and for the last 5 years (2019-2023) was 0%.